AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Context Therapeutics Inc. Director's Dealing 2021

Dec 17, 2021

34269_dirs_2021-12-17_dfb20927-72ac-466a-894b-7b2d8f1869b8.zip

Director's Dealing

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: Context Therapeutics Inc. (CNTX)
CIK: 0001842952
Period of Report: 2021-10-19

Reporting Person: Dick Evan G. (SVP of R&D)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	56373	Direct

Footnotes

F1: Includes 33,397 restricted stock units which fully vest on January 31, 2023.